Core 2

$101,894U54FY2013CANIH

Arizona State University-Tempe Campus, Tempe AZ

Investigators

Linked publications, trials & patents

Paper 35412430 Paper 33279516 Paper 33093162 Paper 32320972 Paper 31900199 Paper 31694907 Paper 30455303 Paper 30291105 Paper 29915189 Paper 29766388 Paper 29717454 Paper 28809863 Paper 27790711 Paper 27630194 Paper 27503568 Paper 27212425 Paper 27121793 Paper 26934674 Paper 26813872 Paper 26702772 Paper 26240372 Paper 26216839 Paper 26186366 Paper 26021206 Paper 25996033 Paper 25994221 Paper 25663616 Paper 25492499 Paper 25297728 Paper 25163529 Paper 25043755 Paper 24859205 Paper 24793120 Paper 24737864 Paper 24737863 Paper 24677773 Paper 24389542 Paper 24361676 Paper 24180289 Paper 24178577 Paper 24144978 Paper 23874207 Paper 23620291 Paper 23618955 Paper 23604118 Paper 23602475 Paper 23468649 Paper 23463310 Paper 23196865 Paper 23159919 Paper 23088423 Paper 22751117 Paper 22735523 Paper 22677392 Paper 22406828 Paper 22242161 Paper 22170739 Paper 22085965 Paper 22009203 Paper 21559520 Paper 21301067 Paper 21301065 Paper 21182180 Paper 21076404 Patent 9981997 Patent 10336713 Patent 10287257

Abstract

The Materials Core (Biological Sample and Processing) is comprised ofthe Fred Hutchinson Cancer Research Center (FHCRC) and the Mayo Clinic Scottsdale. The two entities will be responsible for providing cell line and tissue reagents in support of all projects within the Center and will support the development of common reagents. Each project research plan requires well-characterized cell lines and primary tissues to further the experimental goals ofthe Center. The FHCRC portion ofthe Core will be under the direction of Dr. William Grady, who will manage the cell lines used in projects 1 through 3. The Mayo Clinic portion ofthe Core will be under the direction of Dr. Joseph Mikhaels, who will coordinate the collection and characterization of tissues. The cell lines that will be maintained and distributed to researchers are colon adenoma and adenocarcinoma and Barrett's Esophagus and esophageal adenocarcinoma cell lines. Primary tissue samples will be collected during endoscopy and colonoscopy following procedures approved by the Institutional Review Board at Mayo Clinic.

View original record on NIH RePORTER →